Publications
5891 Results
- Journal / Conference
- Journal of the National Cancer Institute 101(5):283-295
- Year
- 2009
- Research Committee(s)
- Prevention, Screening, and and Surveillance
- Study Number(s)
- S0000
Selenium and vitamin E: interesting biology and dashed hope. PMID: 19244172
- Journal / Conference
- Recent Results in Cancer Research 181:183-193
- Year
- 2009
- Research Committee(s)
- Prevention, Screening, and and Surveillance
- Study Number(s)
- S0000
Selenium and Vitamin E Cancer Prevention Trial: a nutrient approach to prostate cancer prevention. PMID: 19213568
- Journal / Conference
- Blood 114:abst.#111 (ASH Annual Meeting, oral presentation)
- Year
- 2009
- Research Committee(s)
- Lymphoma
- Study Number(s)
- SWOG-8809, S9800, S9911
Fc gamma receptor 3a genotype predicts overall survival for follicular lymphoma patients treated on Southwest Oncology Group trials with combined monoclonal antibody plus chemotherapy but not chemotherapy alone
- Journal / Conference
- Blood 114:abst. #620, 2009 (ASH Annual Meeting, oral presentation)
- Year
- 2009
- Research Committee(s)
- Lymphoma
- Study Number(s)
- SWOG-8819
Accurate classification of diffuse large cell lymphoma into germinal center and activated B cell subtypes using a nuclease protection assay on formalin fixed paraffin embedded: a study from the Lymphoma and Leukemia Molecular Profiling Project
- Journal / Conference
- Blood 114:abst. #1948 (ASH Annual Meeting, poster presentation)
- Year
- 2009
- Research Committee(s)
- Lymphoma
- Study Number(s)
- SWOG-8819
High microvascular density correlates independently with poor outcome in patients with diffuse large B-cell lymphoma (DLBCL) treated with rituximab plus chemotherapy (R-CT)
- Journal / Conference
- Blood 114 abst. #2922 (ASH Annual Meeting, poster presentation)
- Year
- 2009
- Research Committee(s)
- Lymphoma
- Study Number(s)
- SWOG-8819
Chromosomal alterations in gene expression-defined pediatric aggressive B-cell non-hodgkin lymphomas (B-NHL)
- Journal / Conference
- Blood 114:abst. 1100 (ASH Annual Meeting, poster presentation)
- Year
- 2009
- Research Committee(s)
- Lymphoma
- Study Number(s)
- SWOG-8819
MYC translocations and expression are clinically important in R-CHOP treated patients with de novo DLBCL
- Journal / Conference
- Blood 114:abst. #790
- Year
- 2009
- Research Committee(s)
- Leukemia
- Study Number(s)
- S0106
Preliminary results of Southwest Oncology Group study S0106: an international intergroup phase 3 randomized trial comparing the addition of gemtuzumab ozogamicin to standard induction therapy versus standard induction therapy followed by a second randomization to no additional therapy versus post-consolidation gemtuzumab ozogamicin for previously untreated acute myeloid leukemia
- Journal / Conference
- Journal of Clinical Oncology, 27(24):3881-3886
- Year
- 2009
- Research Committee(s)
- Breast
- Study Number(s)
- SWOG-9313
Outcome of patients with early-stage breast cancer treated with doxorubicin-based adjuvant chemotherapy as a function of HER2 and TOP2A status [PMC2734394; PMID19620488]
- Journal / Conference
- International Journal of Cancer 124(9)2082-2087
- Year
- 2009
- Research Committee(s)
- Cancer Control
- Study Number(s)
- SWOG-9217